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 Abstract: 
Background: Genome scan in Chinese revealed an association of blood pressure with the 
microsatellite marker D17S1303, which lies in a quantitative trait locus for the abdominal 
obesity-metabolic syndrome (AOMS2) at 17p12 on chromosome 17.  We previously 
reported that D17S1303 was associated with hypertension and obesity.    Therefore, we 
studied 10 single nucleotide polymorphisms (SNP) within 3kb of D17S1303. 
Methods: 180 hypertensive subjects (91 men, 89 women, age 53+12) and 180 normotensive 
matched controls (91 men, 89 women, age 52+11) were genotyped using the Sequenom 
genotyping platform.  
Results:  Allelic frequencies in these Chinese subjects differed from those reported for 
Caucasians.  Three SNPs (rs11656507, rs1357926, rs852319) were homozygous in our 
subjects.  The genotype frequencies of rs852320, rs852321 and rs852322 did not differ 
between hypertensive and normotensive subjects.  However, there were significant 
differences for rs1525402 (p=0.048), rs2692343 (p=0.022), rs2692344 (p=0.017) and 
rs2321313 (p=0.028).  A 4-locus haplotype comprising G at rs1525402, C at rs2692343, C 
at rs2692344 and G at rs2321313 was associated with lower systolic blood pressure (p=0.023) 
and normotension (p=0.048).   
Conclusion:  Our results provide further evidence that there is a gene, as yet unidentified, 
influencing blood pressure in the vicinity of D17S1303 in a quantitative trait locus for 
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 abdominal obesity-metabolic syndrome at 17p12.   
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 Introduction: 
Patients with hypertension usually do not have a secondary cause. Primary or essential 
hypertension is likely to result from the interaction between genetic predisposition and 
environmental factors.1  The environmental factors that lead to hypertension are well 
worked out.  Of these, overweight or obesity is undoubtedly one of the most important.2  
The search for causative genes for hypertension has been ongoing for at least a decade.  
Many promising candidate genes have been examined.  Thus, a gene that causes 
hypertension may also be associated with obesity and other components of the metabolic 
syndrome. 
 
A genome scan of blood pressure-regulating genes done in Chinese sib pairs undertaken in 
Anhui in collaboration with Harvard University showed that the microsatellite marker 
D17S1303, which consists of GATA repeats, had a high LOD score.3  This marker lies close 
to a quantitative trait locus for abdominal obesity-metabolic syndrome (AOMS2) at 17p12 on 
chromosome 17.4  Recently, we have reported that D17S1303 was associated with 
hypertension.5  The number of GATA repeats correlated inversely with diastolic blood 
pressure and BMI.  Nine GATA repeats were associated with hypertension whilst 14 GATA 
repeats were associated with normotension. 
 
 4
 Chromosome 17 has been studied in genome scans,6, 7 but the region around D17S1303 has 
not been intensively studied and there is a lack of reports of single nucleotide polymorphisms 
or genes in its close proximity.  In case-control studies, single nucleotide polymorphisms are 
preferable to microsatellite markers, which are highly polymorphic.  Therefore, we set out to 
study SNPs around D17S1303 and investigate their association with hypertension. 
 
Methods: 
Subjects 
The study protocol was approved by the Faculty Ethics Committee.  We studied 360 
subjects, 180 hypertensive patients and 180 normotensive controls with their informed 
consent. Hypertensive subjects were recruited from the Hypertension Clinic of a teaching 
hospital. Hypertension was defined as systolic blood pressure ≥140 mmHg, or a diastolic 
blood pressure ≥90 mmHg on at least 3 separate occasions. Patients on antihypertensive 
treatment and had been diagnosed as hypertensive by the above criteria were also eligible. 
Patients with secondary hypertension (e.g. Cushing’s syndrome, Conn’s syndrome, 
phaeochromocytoma, acromegaly, renal artery stenosis, coarctation, glomerulonephritis and 
pyelonephritis) were excluded. Subjects who received drug treatment for diabetes mellitus 
were also excluded.  Normotensive controls, matched for age and sex, were recruited from 
the Hong Kong Cardiovascular Risk Factor Prevalence Survey-2 (CRISPS2) cohort.  These 
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 subjects had been randomly chosen from the general population.8, 9  
 
Physical examination (including measurement of height, weight, body fat, waist and hip 
circumference), urinalysis and electrocardiography were performed and a full medical history 
(including past medical history, drug history, family history, smoking status, alcohol intake 
and exercise habit) was obtained.  Waist circumference was measured half way between the 
xiphisternum and the umbilicus while hip circumference was measured at the level of the 
greater trochanters.10  Percentage body fat was estimated by measuring the bioelectrical 
impedance (Tanita TBF300, Tanita Corporation, Tokyo, Japan).11   
 
Subjects were studied in the morning after fasting overnight.  The blood pressure of each 
patient was measured by a trained nurse manually after at least 5 minutes of rest. Blood 
pressure was measured thrice at 5 minute intervals. The first measurement was to familiarise 
the patient with the procedure. The 2 subsequent systolic and phase V diastolic blood 
pressure readings were recorded to the nearest 2 mmHg, the mean of which was used for data 
analysis.  
 
After resting for at least 5 minutes, 20 ml venous blood was taken from a forearm vein for a 
full blood count (haemoglobin, haematocrit, differential white count and platelet count), renal 
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 and liver function tests (sodium, potassium, urea, creatinine, glucose, bilirubin, albumin, ALT 
and alkaline phosphatase), plasma insulin and lipid profile.  Insulin resistance was measured 
using the homeostasis model assessment of insulin resistance index (HOMA-IR), which is the 
product of the fasting plasma insulin (FPI) concentration in mU/L and fasting plasma glucose 
(FPG) in mmol/L divided by 22.5.12  Pancreatic β-cell function was estimated using 
HOMA-β%, which equals (20 X FPI)/(FPG – 3.5).   
   
Genetic analysis 
Genomic DNA was extracted from the buffy coat using the QIAamp DNA Mini Kit (Qiagen, 
Hilden, Germany) according to the manufacturer's protocol. Candidate SNPs within 3kb of 
D17S1303 were selected from an SNP database (Fig. 1).13 High-throughput genotyping of the 
SNPs was performed using the Sequenom MassARRAY system (Sequenom, San Diego CA) 
which utilises Matrix Assisted Laser Desorption Ionization-Time Of Flight (MALDI-TOF) 
technology. Primers for SNP detection were designed using MassARRAY AssayDesign 
software (Sequenom).  
 
Statistical analysis 
Data were analysed using a statistical software programme (SPSS for Windows, ver. 11.0, 
SPSS Inc., Chicago, USA). Comparison of clinical characteristics in the hypertensive and 
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 normotensive groups or in groups with different genotypes were performed using unpaired t 
test or Mann-Whitney U test and Chi-square test for continuous and categorical variables 
respectively. Genotype frequencies for each SNP were tested for Hardy-Weinberg equilibrium. 
We used the programme Haploview (ver. 3.2) to calculate the r2 among all possible SNP pairs 
in order to assess the degree of linkage disequilibrium.14  The parameter r2 is independent of 
allele frequency and is appropriate for modest sample sizes.15. 16  Haplotypes were predicted 
using the programme PHASE (version 2.1), which implements a Bayesian method for 
estimating haplotypes from population genotype data.17-19  A 2-tailed p-value less than 0.05 
was considered statistically significant.  With the study sample size, there was 95% power to 
detect an odds ratio of 2.5 for a minor allele with a frequency greater than 0.1. 
 
Results 
Baseline characteristics 
Table 1 shows the characteristics of the 180 hypertensive subjects and 180 normotensive 
controls studied. There were no significant differences in the male:female ratio, age and 
alcohol consumption between the normotensive and hypertensive groups, but there were as 
expected, significant differences in blood pressure, weight, BMI, percentage body fat, 
HDL-cholesterol, plasma insulin and HOMA-IR.  In the hypertensive group, 45 subjects 
(25%) were on antihypertensive drug treatment.   
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SNP genotyping  
Table 2 shows the pairwise r2 among genotyped SNPs.  Three SNPs (rs11656507, 
rs1357926, rs852319) were homozygous in our subjects and therefore not shown.  The 
average r2 value across all SNP pairs was 0.46.  The SNP pairs, rs852321 and rs852322, and 
the three SNPS, rs2692343, rs2692344 and rs2321313, exhibit a high degree of linkage 
disequilibrium. The results of Sequenom genotyping are shown in Table 3.  Genotype 
frequencies in these Chinese subjects differed from those reported for Caucasians.13  There 
were no significant deviations of the observed genotype frequencies from Hardy-Weinberg 
equilibrium.  The genotype frequencies of rs852320, rs852321 and rs852322 did not differ 
significantly between hypertensive and normotensive subjects (p=0.171, p=0.464 and 
p=0.196 respectively).  However, the genotype frequencies of rs1525402, rs2692343, 
rs2692344 and rs2321313 differed between hypertensive and normotensive subjects (p=0.048, 
p=0.022, p=0.017 and p=0.028 respectively) (Table 3).   
 
Table 4 shows the systolic and diastolic blood pressure in subjects with different genotypes.  
The AA genotype at rs1525402 was associated with higher systolic blood pressure (p=0.02).  
There was a small difference in systolic blood pressure between subjects with or without the 
CC genotype at rs2692344 (p=0.049). 
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Haplotypes 
Four–locus haplotypes made up of rs1525402, rs2692343, rs2692344 and rs2321313 were 
analysed.  Table 5 shows the frequencies of ACCG, AAGA and GCCG haplotypes.  ACCG 
and AAGA were common and had a frequency of 0.445 and 0.443, respectively.  ACCG 
was not associated with hypertension (p=0.908) but AAGA was more common among 
hypertensive subjects (p=0.022).  GCCG had a frequency of 0.109 and was less common 
among hypertensive patients (p=0.048).  The GCCG haplotype was associated with lower 
systolic blood pressure (p=0.023) (Table 6). 
 
Stepwise regression with hypertension as the dependent variable and the various SNPs and 
haplotypes as independent variables showed that rs2692343 was the best predictor of 
hypertension (β=0.058, p=0.021).  Neither rs2692343, other SNPs or any of the haplotypes 
are related significantly to body mass index, waist circumference and percentage body fat. 
 
Discussion 
The most important finding of this study was the association of several SNPs at 17p12 with 
hypertension.  The haplotype comprising G at rs1525402, C at rs2692343 and rs2692344, 
and G at rs2321313 was associated with lower systolic blood pressure and was less frequent 
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 among hypertensive patients.  These new findings confirm and extend previous reports of 
the association of 17p12 with hypertension.3-5 
 
Our findings should be interpreted with a degree of caution.  SNPs that are close to each 
other would be expected to show linkage disequilibrium and similar associations with a 
particular trait.  Therefore, the association of several SNPs or a haplotype with hypertension 
may be more a single SNP effect.  Moreover, there might be other as yet unidentified SNPs 
in the region that are more strongly associated with hypertension.  Conversely, our study did 
not have the power to detect weak associations between SNPs and hypertension.  Thus, 
there is a need for replication of our study in an independent and larger data set. 
 
In our population, blood pressure is related to indices of obesity and sodium intake.2, 20-22  
The relationship between obesity and raised blood pressure is expected because both are 
components of the metabolic syndrome, which is a clustering of abdominal obesity, elevated 
blood pressure, blood glucose and triglycerides, and low levels of high density lipoprotein 
cholesterol (HDLC).23  Insulin resistance is believed to be a key underlying metabolic 
abnormality in the syndrome.24, 25  Our hypertensive and age and sex matched normotensive 
subjects differed not just in blood pressure, but also in the other aspects of the metabolic 
syndrome.  We believe that obesity, particularly central obesity, is an early abnormality in 
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 the cardiovascular continuum.10, 26  Increased abdominal adiposity leads to a state of chronic 
low grade inflammation, insulin resistance and endothelial dysfunction.27-29  Adipocytes in 
adipose tissues secrete adipokines such as leptin, adiponectin and acylation-stimulating 
protein (ASP) that regulate obesity.30  Leptin suppresses appetite, whilst adiponectin 
increases insulin sensitivity.  ASP, a cleavage product of complement C3, stimulates 
triacylglycerol synthesis and its storage in adipocytes.  Genome scan revealed two loci, 
3q27 and 17p12, associated with the metabolic syndrome.4  The former is near the 
adiponectin gene.  The latter, AOMS2, is related to plasma levels of leptin4 and ASP.31  
Neither the gene coding for leptin nor ASP (C3) is on chromosome 17, so there is an 
unidentified gene in this locus that determines abdominal obesity.  The polymorphisms we 
investigated all lie within this quantitative trait locus.  This locus is associated with 
hypertension, as shown in the genome scan in Chinese sib-pairs in Anhui.3  We previously 
reported that D17S1303 was associated with hypertension and obesity.5  We now found four 
SNPs that are a few kilobases from D17S1303 and within the AOMS2 quantitative trait locus 
are associated with hypertension.  These consistent findings in different populations using 
diverse genetic approaches collectively suggest a high probability of a disease susceptibility 
gene in the locus. 
 
In conclusion, our study showed that SNPs at 17p12 in Hong Kong Chinese are associated 
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 with hypertension.  This is further evidence that a gene influencing blood pressure is in the 
vicinity of D17S1303, in a quantitative trait locus for abdominal obesity-metabolic syndrome. 
Our results should prompt the fine mapping of this part of chromosome 17, so as to identify 
the gene linked to hypertension and the metabolic syndrome, although final proof would 
require study of the function and dysfunction of the gene.32     
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Figure 1 The locations of the SNPs investigated and the microsatellite marker D17S1303 on 
chromosome 17. 
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 Table 1.  Subjects Characteristics 
 
 Normotensive  
Controls 
N = 180 
Hypertensive 
 
N = 180 
P 
Age (years) 51.9 ± 10.8 53.1 ± 11.9 0.29 
Gender (M: F) 91: 89 91: 89 1.0 
Regular smoking (%) 26 12 0.004 
Regular drinking (%) 12 10 0.58 
Systolic blood pressure (mmHg) 115.5 ± 12.1 144.9 ± 16.4 < 0.001 
Diastolic blood pressure (mmHg) 72.9 ± 8.0 90.8 ± 10.6 < 0.001 
Body weight (kg) 60.2 ± 10.2 65.2 ± 11.7 < 0.001 
Body mass index (kg/m2) 23.2 ± 3.0 25.5 ± 4.0 < 0.001 
Waist circumference (cm) 77.8 ± 8.8 84.4 ± 9.8 < 0.001 
Body fat (%) 27.4 ± 7.7 31.4 ± 9.0 < 0.001 
Fasting glucose (mmol/L) 5.1 ± 0.7 5.2 ± 0.9 0.16 
Plasma insulin (mIU/L) 6.8 (4.6-9.2) 7.4 (5.4-11.0)  0.009 
HOMA-IR 1.4 (1.0-2.2) 1.9 (1.2-2.7)   0.005 
HOMA-β% 91.0 (64.0-119.6) 93.8 (67.3-150.0) 0.10 
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 Total cholesterol (mmol/L) 5.1 ± 0.7 5.4 ± 1.0 0.008 
LDL-cholesterol (mmol/L) 3.1 ± 0.7 3.3 ± 0.9 0.03 
HDL-cholesterol (mmol/L) 1.5 ± 0.4 1.4 ± 0.4 0.03 
Triglycerides (mmol/L) 1.2 ± 0.7 1.6 ± 1.1 < 0.001 
Unless otherwise specified, data are expressed as mean ± SD, or median (interquartile range). 
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 Table 2 
Pairwise r2 among the genotyped SNPs 
 
rs852320       
0.098 rs852321      
0.098 0.994 rs852322     
0.762 0.076 0.075 rs1525402    
0.128 0.641 0.648 0.099 rs2692343   
0.126 0.644 0.651 0.098 0.994 rs2692344  
0.129 0.639 0.646 0.099 0.989 0.994 rs2321313 
The r2 values that are 0.9 or higher are shown in bold type. 
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 Table 3 
Genotype and allele frequencies of SNPs in normotensive and hypertensive subjects  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SNP Genotype Normotensive Hypertensive p-value (odds ratio) 
rs852320 TT 70.8% 76.2% 0.171(0.759) 
 TG 27.7% 20.1%  
 GG 1.5% 3.7%  
   
rs852321 CC 42.4% 39.3% 0.464(1.141) 
 CT 42.8% 46.1%  
 TT 14.8% 14.6%  
   
rs852322 GG 43.3% 36.1% 0.196(1.353) 
 GA 40.6% 48.9%  
 AA 16.1% 15.0%  
   
rs1525402 AA 75.6% 84.4% 0.048(0.569) 
 AG 22.8% 13.3%  
 GG 1.7% 2.2%  
   
rs2692343 CC 36.7% 25.0% 0.022(1.737) 
 CA 43.9% 55.0%  
 AA 19.4% 20.0%  
   
rs2692344 CC 36.9% 25.0% 0.017(1.752) 
 CG 43.6% 55.6%  
 GG 19.6% 19.4%  
   
rs2321313 GG 35.8% 24.9% 0.028(1.685) 
 GA 44.3% 55.9%  
 AA 19.9% 19.2%  
   
Subjects carrying one or both minor alleles were grouped together 
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 Table 4 
Blood pressure and genotypes  
 
SNP  Genotype N Mean (mmHg) p-value 
rs1525402 Systolic BP AA 288 131.45±1.219 0.020 
  AG+GG 72 125.17±2.319  
 Diastolic BP AA 288 81.84±0.768 0.963 
  AG+GG 72 81.76±1.493  
     
rs2692343 Systolic BP CC 111 127.26±1.660 0.071 
  CA+AA 249 131.50±1.380  
 Diastolic BP CC 111 82.04±1.162 0.839 
  CA+AA 249 81.73±0.841  
     
rs2692344 Systolic BP CC 111 127.26±1.660 0.049 
  CG+GG 248 131.53±1.385  
 Diastolic BP CC 111 82.04±1.162 0.088 
  CG+GG 248 81.82±0.840  
     
rs2321313 Systolic BP GG 107 127.48±1.715 0.066 
  GA+AA 246 131.55±1.395  
 Diastolic BP GG 107 82.23±1.184 0.693 
  GA+AA 246 81.64±0.851  
 
Data are expressed as mean ± SE 
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 Table 5  
Haplotype frequencies in normotensive and hypertensive subjects 
 
Haplotype Haplotype 
frequency 
from  
PHASE 
Genotype Normotensive Hypertensive p-value 
(odds ratio) 
ACCG 0.445 Non-carrier 30.2% 29.4% 0.908
(1.035)
  1 copy carrier 48.6% 53.9% 
  2 copies carrier 21.2% 16.7% 
   
AAGA 0.443 Non-carrier 36.3% 25.0% 0.022
(1.711)
  1 copy carrier 44.1% 55.6% 
  2 copies carrier 19.6% 19.4% 
   
GCCG 0.109 Non-carrier 76.0% 84.4% 0.048
(0.583)
  1 copy carrier 22.3% 13.3% 
  2 copies carrier 1.7% 2.2% 
   
 
The four–locus haplotypes consist of rs1525402, rs2692343, rs2692344 and rs2321313. 
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 Table 6  
Systolic blood pressure and haplotypes  
 
Haplotype  N Systolic blood 
pressure 
(mean±SE, mmHg) 
p-value 
ACCG Non-carrier 107 130.0±2.1 0.908 
 Carrier(1 or 2 copies) 252 130.3±1.3  
     
AAGA Non-carrier 110 127.3±1.7 0.055 
 Carrier (1 or 2 copies) 249 131.5±1.4  
     
GCCG Non-carrier 288 131.5±1.2 0.023 
 Carrier (1 or 2 copies) 71 125.2±2.4  
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 Figure 1 
The locations of the SNPs investigated and the microsatellite marker D17S1303 on 
chromosome 17. 
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  28
What is known on this topic 
Hypertension is more common in obese people.  There is a quantitative trait locus for the 
abdominal obesity-metabolic syndrome on chromosome 17.   A microsatellite, D17S1303, 
that lies in this quantitative trait locus has previously been found to be associated with 
hypertension.     
 
What this paper adds 
Four single nucleotide polymorphisms within 3 kilobases of D17S1303 were found to be 
associated with hypertension in this case control study.  This provides further evidence that 
a gene predisposing to hypertension in Chinese is in this region of chromosome 17.   
 
